Navigation Links
Spherix Incorporated to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
Date:9/6/2011

ical devices, consumer products and industrial chemicals and pesticides.  For more information, please visit www.spherix.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of D-tagatose, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our continuing efforts to develop D-tagatose may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market, and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Spherix Announces Second Quarter Financial Results
2. Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions in Serum Triglycerides in Preclinical Testing
3. Spherix Announces Registered Direct Offering of $2.77 Million
4. Spherix Announces Post-Hoc Analysis of Phase 3 Trial With D-Tagatose in Diabetes
5. Spherix Announces Third Quarter 2010 Financial Results
6. Spherix Awarded Grant from U.S. Government Under the Patient Protection and Affordable Care Act
7. Spherix Announces Institutional Investors Purchase $5.25 Million of Convertible Preferred Stock and Warrants
8. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
9. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
10. Spherix Reports Third Quarter 2009 Earnings
11. Spherix Announces Positive Phase 2 Study Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  Zacks.com announces the list of stocks ... Equity Research analysts discuss the latest news and events ... in the blog include Actavis, Inc.,s (NYSE: ACT ... (NYSE: TOT ), Petrobras (NYSE: PBR ) ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) Get ...
(Date:5/21/2013)... , May 21, 2013  Cephasonics, ... platform, today announced the introduction of the ... complete network-based communications with all cQuest Ultrasound™ ... embedded-ultrasound technology, including this new capability, at ... Paulo, Brazil from May 21-24.  ...
(Date:5/21/2013)... May 21, 2013  Vasomedical, Inc. (OTC BB: VASO) (the ... manufacture and sale of medical devices and in the domestic ... Jun Ma , President and CEO of Vasomedical, ... Conference on Thursday, May 30, 2013 in New ... The Company,s presentation is scheduled to begin at ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2
(Date:5/21/2013)... NY (PRWEB) May 21, 2013 Two-thirds ... or non-small cell lung cancer reported that they engage ... their medicine use, according to new findings from the ... by Kantar Health . The research will be ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research) in ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... was voted #1 for plastic surgery SEO services ... respondents were asked to name the “Best Plastic ... services say the outcome was predictable. Well-known in ... identified more by patients than any other selection ...
(Date:5/21/2013)... 2013 It’s nearly summer and millions of ... starting practice for summer or fall sports. In many ... activities can begin. , To help parents during this ... sports or camp physicals at just $29. ... a child’s medical history, perform a physical exam and complete ...
(Date:5/21/2013)... Nearly 40 Platinum Supplemental Insurance Sales Representatives and ... Cabos, Mexico, Feb. 23-March 1, 2013, to help renovate Casa ... facility serves meals and provides a social outlet for 45 ... Platinum Vice President, Mike Muench, says that the idea for ... “Platinum got its start selling long-term care insurance ,” ...
(Date:5/21/2013)... 2013 Access MediQuip, LLC , ... company, announced today that it has expanded its national ... nation's largest health benefits companies, with more than 36 ... 66 million individuals served through its subsidiaries. , WellPoint ... implant management program agreement back in 2008. Under the ...
Breaking Medicine News(10 mins):Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 2Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 3
... results from a large-scale study of key antimalarial medicines ... percentage of medicines circulating on national markets are of ... of drug-resistant strains of Plasmodium falciparum , the ... by the Promoting the Quality of Medicines (PQM) Program, ...
... of advanced breast cancer diagnosis among black women remained ... women between 1992 and 2004, according to new findings ... addition, the disparity in the incidence of advance colorectal ... fell among whites but increased slightly among blacks. , ...
... ... significant achievement and differentiates Hallmark Insights from its peers in the incentive services ... (PRWEB) ... that it has successfully completed a Statement on Auditing Standards (SAS) 70 Type II ...
... Small study reports improvement in thinking skills, , ... drug may improve thinking, learning and memory skills ... disorder, new research says. , Huntington,s affects movement, ... disease usually die within 10 to 30 years ...
... brass support improved school nutrition to cut obesity, ensure qualified recruits ... Johnnie E. Wilson , U.S. Army (Ret.), and Lieutenant General ... preventing child obesity is a matter of national security, noting that ... are unable to enlist in the armed services. The generals, comments ...
... , Feb. 9 The National ... join the Commission on Cancer (CoC), a multidisciplinary organization administered ... morbidity and mortality of cancer through education, standards setting, and ... has invited NCCS, a key patient advocacy organization, to join ...
Cached Medicine News:Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 2Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 3Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 4Health News:Hallmark Insights Completes SAS 70 Type II Audit 2Health News:Drug May Ease Cognitive Effects of Huntington's 2Health News:Retired Military Brass Support First Lady's Call to Reduce Child Obesity, Improve Nutrition 2Health News:The National Coalition for Cancer Survivorship Joins the Commission on Cancer 2
... new Propaq LT is the perfect monitor ... basic parameters of continuous vital signs monitors ... making it perfect for just about any ... Light enough to clip on an IV ...
Exxcel Soft ePTFE vascular graft, designed for exceptional kink resistance and crush resistance, maintains a Soft touch for easier handling during peripheral vascular bypass procedures and vascular a...
... is used for the processing ... independent medical billers. It is ... generate and transmit claims to ... commercial insurance carriers. It utilizes ...
BillingPro...
Medicine Products: